Authors
Aliev S.A., Aliev E.S., Hummatov A.F.
Azerbaijan Medical University, Baku, Azerbaijan
Abstract
In the review conducted a critical analysis of literature data devoted to modern views of generalized surgical infection. Chronologically outlined the evolutionary stages of formation of scientific concepts about the nature of sepsis, given the identification of most important questions, concerning the definition, unification of terminology and classification of sepsis since the resolution of the consensus conference ACCP/SCCM (1991). In this and subsequent conciliation conferences (2001; 2012; 2016) presents a unified criteria for definition and classification sepsis with taking in co account all modifications, providing concise definetions and availability of diagnostic criteria. In review were given key provisions of the recommendations of the “Sepsis-3”, according to which in contrast to previous recommendations and instead of the previously accepted categories of generalized surgical infection, it is proposed to use only two is a sepsis and septic shock. In accordance with the consensus “Sepsis-3” sepsis is defined as life-threatening organ dysfunction due to dysrequlation of the response to infection, the key symptom of which is that the way in which the body damages its own organs and tissues.
Keywords: sepsis, systemic inflammatory response syndrome, severe sepsis, septic shock, organ dysfunction, definitions, consensus.
References
1. Bauman ZM, Killu KF, Rech MA, et al. Racial differenses in vasopressor requirements for septic shock. Shock. 2014;41(3):188–192. Doi: 10.1097/SHK.0000000000000103.
2. Vershinina MG, Kukhtina NB. Laboratory sepsis diagnostic in multidisciplinary hospital. Khirurgiia. 2014;(6):74–76. (In Russ).
3. Gel’fand BR, Rudnov VA, Galstyan GM, et al. Sepsis: terminologiya, patogenez, kliniko-anatomicheskaya kontseptsiya. Voprosy ginekologii, akusherstva i perinatologii. 2017;(1):64–72. (In Russ).
4. Lazanovich VA, Stepanyuk VN, Smirnov GA, et al. Biomarkery vospaleniya v prognoze iskhoda abdominal’nogo sepsisa. Fundamental’nye issledovaniya 2012;4(2):311–315. (In Russ).
5. Iwashyna TJ, Govindan S. Did they just prove that a diagnosis of septic shock is meaningless? Am J Respir Crit Care Med. 2014:189(10):1156–1157. Doi: 10.1164/rccm.201404-0632.
6. Grachev SV, Pak SG, Malov VA, Gorodnova EA. Sovremennye aspekty patogeneza sepsisa. Terapevticheskii arkhiv. 2003;(11):84–89. (In Russ).
7. Briskin BS, Hachatrjan NN, Savchenko ZI, et al. Abdominal'nyi sepsis, vozmozhnosti antibakterial'noi i immunokorrigiruyushchei terapii. Khirurgiia. 2002;(4):69–74. (In Russ).
8. McPherson D, Griffiths C, Williams M, et al. Sepsis-associted mortality in England an analysis of multiple cause of death data from 2001 to 2010. BMJ Open. 2013;3(8);002586. Doi: 10.1136/bmjopen.2013.002586.
9. Karsanov AM, Maskin SS, Slepushkin VD, et al. Kliniko-epidemiologicheskoe znachenie sistemnogo vospaleniya i sepsisa. Vestnik khirurgii. 2015;174(4):99–103. (In Russ).
10. Karsanov AM, Remizov OV, Maskin SS, et al. Diagnostika sepsisa. Vestnik khirurgii. 2016;175(6):98–103. (In Russ).
11. Krivopalov AA, Yanov YuK, Shatalov VA, et al. Kliniko-diagnosticheskie osobennosti otorinosinusogennykh vnutricherepnykh gnoino-vospalitel'nykh zabolevanii, oslozhnivshikhsya sepsisom. Vestnik khirurgii. 2016;175(6):13–19. (In Russ).
12. Larichev AB. Snova o sepsise: filosofiya dialekticheskogo edinstva definitsii i klinicheskoi praktiki. Khirurgiia. 2015;(10):84–87. (In Russ).
13. Kochetkov AV, Gudilov MS. Kliniko-laboratornaja diagnostika gnojno-septicheskih oslozhnenij posle operacij na organah brjushnoj polosti. Novosti khirurgii. 2015;23(1):105–111. (In Russ).
14. Ostanin AA, Leplina OYu, Tikhonova MA, et al. Khirurgicheskii sepsic. Chast' I. Immunologicheskie markery sistemnoi vospalitel'noi reaktsii. Vestnik khirurgii. 2002;(3):101–107. (In Russ).
15. Nessler N, DefontaineA, Lanney Y, et al. Long-term mortality and quality of life after septic shock: a follow-up observational study. Intensive Care Med. 2013;39(5):881–888. Doi: 10.1007/s00134.013-2815-1.
16. Rudnov VA, Kulabukhov VV. Sepsis. Evolyutsiya predstavlenii, neobkhodimost' unifikatsii terminologii i kriteriev diagnoz. Khirurgiia. 2000;(4):36–40. (In Russ).
17. Sazhin VP, Karsanov AM, Maskin SS, Remizov OV. Chto takoe sepsis: 25-letnii opyt razvitiya kontseptsii. Khirurgiia. 2017;(1):82–87. (In Russ).
18. Savel’ev VS, Gel’fand BR. Sepsis v nachale XXI veka. Klassifikacija, kliniko-diagnosticheskaja koncepcija i lechenie. Patologicheskaja diagnostika. Prakticheskoe rukovodstvo. Moscow: Litterra; 2006. (In Russ).
19. Mishnev OD, Grinberg LM, Zairat'yants OV. Aktual'nye problemy patologii sepsisa: 25let v poiskakh konsensusa. Arkhiv patologii. 2016;78(6):3–8. (In Russ).
20. Nazaret’yan VV, Lukach VN, Kulikov AV. Prediktory neblagoprijatnogo ishoda u pacientov s abdominal’nym sepsisom. Anesteziologiya i reanimatologiya. 2016;61(3):209–214. (In Russ).
21. Eryukhin IA, Shlyapnikov SA. Khirurgicheskii sepsis. Khirurgia. 2000;(3):44–46. (In Russ).
22. Angus DC, van der Poll Т. Severe sepsis and septic shock. N Engl J Med. 2013;369(9):840–851. Doi: 10.1056/NEJMra1208623.
23. Annane D, Sebille V, Charpentier C, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA. 2002;288(7):862–871. Doi: 10.1001/jama.288.7.862.
24. Bone RC. Let’s agree on terminology: definitions of sepsis. Crit Care Med. 1991;9(7):973-976.
25. Bone RC, Balk RA, Cerra FB. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest. 1992;101(6);1644–1655. Doi: 10.1378/Chest.101.6.1644.
26. Bone RC, Balk RA, Cerra PB, et al. Definitions for sepsis and organ failure guidelines for use innovative therapies in sepsis. Cir Care Med. 1992;20:864–874. Doi: 10.1161/01.CIR.0000023891.80661.
27. Воnе RC, Sibbald WJ, Sprung CL. The ACCP-SCCM consensus conference on sepsis and organ failure. Chest. 1992;101(6):1481–1483.
28. Cuthbertson BH, Elders A, Hall S, et al. Mortality and quality of life in the five after severe sepsis. Crit Care. 2013;17(2):70–78. Doi: 10.1186/cc12616.
29. Chen YX, Li CS. Evaluation of community-acquired sepsis by PIRO system in the emergency department. Int Emerg Med. 2013;(6):521–527. Doi: 10.1007/s117390-013-0969-z.
30. Churpek MM, Zadravecz FJ, Winslow C, et al. Incidence and prognostic value of the systemic inflammatory response syndrome and organ dysfunctions in ward patients. Am J Respir Crit Care Med. 2015;192(8):958–964. Doi: 10.1164/rccm.201502-0275OC.
31. Delaney A, Peake SL, Bellomo R, et al. Australasian resuscitation in sepsis evaluation trial statistical analysis plan. Emeg Med Australas. 2013;25(5):406–415. Doi: 10.1111/1742-6723.12116.
32. Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock. Crit Care Med. 2013;41(2):580–637. Doi: 10.1097/CCM0000000000001664.
33. Donnelly JP, Hohmann SF, Wang HE. Unplanned readmissions after hospitalization for severe sepsis at academic medical center-affiliated hospitals. Crit Care Med. 2015;43(9):1916–1927. Doi: 10.1097/CCM0000000000001147.
34. Fleischmann C, Scherag A, Adhikari NK, et al. Assessment of global incidence and mortality of hospital-treated sepsis current estimates and limitations. Am J Respir Crit Care Med. 2016;193(3):259–272. Doi: 10.1164/rccm201504-0781OC.
35. Gaieski DF, Edwards JM, Kallan MJ, Carr BG. Benchmarking the incidence and mortality of severe sepsis in the United States. Crit Care Med. 2013;41(5):1167–1174. Doi: 10.1097/CCM.obo13e31827c0918.
36. Comstedt P, Storgaard M, Lassen AT. The systemic inflammatory response syndrome (SIRS) in acutely hospitalized medical patients: a cohort study. Scand J Trauma Resusc Emerg Med. 2009;17:67. Doi: 10.1186/1757-7241-17-67.
37. Goodwin AJ, Rice DA, Simpson KN, Ford DW. Frequency, cost, and risk factors of readmissions among severe sepsis survivors. Crit Care Med. 2015;43(4):738–746. Doi: 10.1097CCM.0000000000000859.
38. Horeczko T, Green JP, Panacek EA. Epidemiology of the systemic inflammatory response syndrome (SIRS) in the emergency department. West J Emerg Med. 2014;15(3):329–336. Doi: 10.5811/westjem2013.9.18064.
39. Kaukonen KM, Bailey M, Suzuki S, et al. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zeland, 2000-2012. JAMA. 2014;311(13):1308–1316. Doi: 10.1001/jama.2014.2637.
40. Leligdowicz A, Dodek PM, Norena M, et al. Association between source of infection and hospital mortality in patients who have septic shock. Am J Respir Crit Care Med. 2014;189(10):1204–1213. Doi: 10.1164/rccm.201310-1875OC.
41. Levy MM, Artigas A, Philips GS, et al. Outcomes of the surviving sepsis campaign in intensive care units in the USA and Europe: a prospective cohort study. Lancet Infect Dis. 2012;12(12):919–924. Doi: 10.1016/S1473-3099(12)70239-6.
42. Liu V, Escobar GJ, Greene JD, et al. Hospital deaths in patients with sepsis from 2 independent cohorts. JAMA. 2014;312(1):90–92. Doi: 10.1001/jama.2014.5804.
43. Lucas S. Sepsis definitions. Lancet. 2013;381(29):22–49. Doi: 10.1155/2016/4062829.
44. Martin GS. Sepsis, severe sepsis and septic shock: changes in incidence, pathogens and outcomes. Expert Rev Anti Infect Ther. 2012;10(61):701–706. Doi: 10.1586/eri.12.50.
45. Moore LJ, McKinley BA, Turner KL, et al. The epidemiology of sepsis in general surgery patients. J Trauma. 2011;70(3):672–680. Doi: 10.1097/TAobo13e31820e7803.
46. Ortego A, Gaieski DF, Fuchs BD, et al. Hospital-based acute care use in survivors of septic shock. Crit Care Med. 2015;43(4):729–737. Doi: 10.1097/CCM 0000000000000693.
47. Park DW, Chun BC, Kim JM, et al. Epidemiological and clinical characteristics of community-acquired severe sepsis and septic shock: a prospective observational study in 12 university hospitals in Korea. J Korean Med Sci. 2012;27(11):1308–1314. Doi: 10.3346/jkms.2012.27.11.1308.
48. Prescott HC. Toward a nuanced understanding of the role of infection in readmissions after sepsis. Crit Care Med. 2016;44(3):634–635. Doi: 10.1097/CM0000000000001508.
49. Rivers E, Nguyen D, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345(19):1368–1377. Doi: 10.1056/NEJMoa010307.
50. Russell JA. Management of sepsis. N Engl J Med. 2006;355(16):1699–1713. Doi: 10.1056/NEJMra043632.
51. Rhee C, Gohil S, Klompas M. Regulatory mandates for sepsis care − reasons for caution. N Engl J Med. 2014;370(18):1673–676. Doi: 10.1056/NEJM p1400276.
52. Shankar-Hari M, Bertolini G, Brunkhorst FM, et al. Inding quality of current septic shock definetions and criteria. Crit Care. 2015;19(1):445. Doi: 10.1186/s13054-015-1164-6.
53. Shankar-Hari M, Deutschman CS, Singer M. Do we need a new definition of sepsis? Intensive Care Med. 2015;41(5):909–911. Doi: 10.1007/S00134-015-3680-x.
54. Singer M, Deutschman CS, Seymour CW, et al. International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801–810. Doi: 10.1001/jama.2016.02.87.
55. Opal SM. Severe sepsis and septic shock: defining the clinical problem. Scand J Infect Dis. 2003;35(9):529–534. Doi: 10.1080/00365540310015917.
56. Stevenson EK, Rubenstein AR, Radin GT, et al. Two decades of mortality trends among patients with severe sepsis: a comparative meta-analysis. Crit Care Med. 2014;42(3):625–631. Doi: 10.1097/CCM0000000000000026.
57. Vincent JL, Rello J, Marshall JC, et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA. 2009;302(21):2323–2329. Doi: 10.1001/jama.2009.1754.
58. Vincent JL, Opal SM, Marshall JC, Tracey KJ. Sepsis definitions: time for change. Lancet. 2013;29(381):774–775. Doi: 10.1016/SO140-6736(12)61815-7.
59. Walkey AJ, Lagu T, Lindenauer PK. Trends in sepsis and infection sources in the United States. A population-based study. Ann Am Thorac Soc. 2015;12(2):216–220. Doi: 10.1513/AnnalsATS.201411-498BC.
60. Wang HE, Szychowski JM, Griffin R, et al. Long-term mortality after community-acquired sepsis: a longitudinal population-bared cohort study. BMJ Open. 2014;17(4):121–126. Doi: 10.1136/bmjopen-2013-004283.1.
61. Wang T, Derhovanessian A, De Cruz S, et al. Subsequent infections in survivors of sepsis: epidemiology and outcomes. J Intensive Care Med. 2014;29(2):87–95. Doi: 10.1177/0885066612467162.
62. Morel J, Li JY, Eyenga P, et al. Early adverse changes in liver microvascular circulation during experimental septic shock are not linked to an absolute nitric oxide deficit. Microvasc Res. 2013;90:187–191. Doi: 10.1016/j.mvr.2013.07.005.
63. Madonna R, Jiang J, Geng YJ. Attenuated expression of gelsolin in association with induction of aquaporin-1 and nitric oxide synthase in dysfunctional hearts of aging mice exposed to endotoxin. Int Immunopathol Pharmacol. 2012;25(4):911–922. Doi: 10.1177/039463201202500409.
64. Wang L, Taneja R, Razavi HM, et al. Spesific role of neutrophil inducible nitric oxide synthase in murine sepsis-induced lung injury in vivo. Shock. 2012;37(5):539–547. Doi: 10.1097/SHK.Ob 013e31824dcbsa.
